Glechoma hederacea
Gleason Grade is a system used to evaluate the prognosis of men with prostate cancer. It was developed by Donald Floyd Gleason in the 1960s and is now widely used worldwide. The Gleason Grade is based on the microscopic appearance of prostate cancer and is a strong predictor of tumor behavior.
History
The Gleason Grade was developed by pathologist Donald Floyd Gleason in the 1960s as part of a research project for the Veterans Administration. The grading system was initially met with skepticism but has since been validated by numerous studies and is now widely accepted and used worldwide.
Method
The Gleason Grade is determined by the pathologist who examines the prostate tissue under a microscope. The pathologist looks for patterns in the arrangement of the cancer cells and assigns a grade from 1 to 5, with 1 being the least aggressive and 5 being the most aggressive. The grades are then added together to give a Gleason Score.
Gleason Score
The Gleason Score is the sum of the two most common grades in the tumor. The first number represents the most common grade and the second number represents the second most common grade. For example, if the most common grade is 3 and the second most common grade is 4, the Gleason Score would be 7 (3+4). The higher the Gleason Score, the more aggressive the cancer and the worse the prognosis.
Clinical Significance
The Gleason Grade is a strong predictor of tumor behavior and is used to guide treatment decisions. A low Gleason Score indicates a less aggressive tumor that may not require immediate treatment, while a high Gleason Score indicates a more aggressive tumor that may require more aggressive treatment.
See Also
This article is a medical stub. You can help WikiMD by expanding it!
Ad. Transform your life with W8MD's Budget GLP-1 injections from $29.99


W8MD offers medical weight loss programs including NYC medical weight loss and Philadelphia medical weight loss offering:
- Affordable GLP1 shots (generic and brand names) such as
- Wegovy NYC (Semaglutide)
- Zepbound NYC /
- Learn more: Budget GLP1 weight loss injections NYC & Philadelphia GLP1 weight loss shots
- Most insurances accepted
- Lowest cost GLP1 weight loss NYC such as Semaglutide starting from $29.99/week and $45.00/week (Tirzepatide) with insurance.
- Prescription weight loss NYC including:
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your physician weight loss journey today at our:
- NYC medical weight loss
- Philadelphia medical weight loss
- Call 718-946-5500 for NYC or 215-676-2334 for Philadelphia
- Tags:
Budget glp1 weight loss NYC,
Zepbound NYC,
Philadelphia medical weight loss,
Wegovy NYC,
Zepbound Philadelphia,
Budget GLP1 shots Philadelphia
Facebook_Shiny_Icon YouTube_icon_(2011-2013)
Error creating thumbnail:
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

